Essential and unexpected role of yin yang 1 to promote mesodermal cardiac differentiation

Circulation Research

Volumn 112, Issue 6, 2013, Pages 900-910

  Gregoire, Serge ^a   Karra, Ravi ^b   Passer, Derek ^a   Deutsch, Marcus André ^a,c   Krane, Markus ^a,c   Feistritzer, Rebecca ^a,d   Sturzu, Anthony ^a   Domian, Ibrahim ^a,e   Saga, Yumiko ^a   Wu, Sean M ^a,e  

^a Cardiovascular Research Center   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d NATIONAL INSTITUTE OF GENETICS   (Japan)

^e HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

cardiac development; congenital heart disease; progenitor cell; stem cell

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CONNECTIN; MYOGENIN; MYOSIN 18B; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR YY1; TROPOMYOSIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BINDING SITE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; EMBRYONIC STEM CELL; GENE EXPRESSION; GENETIC ASSOCIATION; HEART DEVELOPMENT; HUMAN; HUMAN CELL; IN VITRO STUDY; MESODERM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; GATA4 TRANSCRIPTION FACTOR; GENOME-WIDE ASSOCIATION STUDY; HOMEODOMAIN PROTEINS; MICE; MYOBLASTS, CARDIAC; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; YY1 TRANSCRIPTION FACTOR;

EID: 84875212339     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.113.259259     Document Type: Article

References (56)

1. Braam SR, Passier R, Mummery CL. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery. Trends Pharmacol Sci. 2009; 30: 536-545.
2. Evans SM, Mummery C, Doevendans PA. Progenitor cells for cardiac repair. Semin Cell Dev Biol. 2007; 18: 153-160.
3. Harvey RP. Regenerative medicine: Heart redevelopment. Nature. 2010; 467: 39-40.
4. Parmacek MS, Epstein JA. Pursuing cardiac progenitors: regeneration redux. Cell. 2005; 120: 295-298.
5. Wu SM, Fujiwara Y, Cibulsky SM, Clapham DE, Lien CL, Schultheiss TM, Orkin SH. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell. 2006; 127: 1137-1150.
6. Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, Chen Y, Qyang Y, Bu L, Sasaki M, Martin-Puig S, Sun Y, Evans SM, Laugwitz KL, Chien KR. Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell. 2006; 127: 1151-1165.
7. Cai CL, Liang X, Shi Y, Chu PH, Pfaff SL, Chen J, Evans S. Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell. 2003; 5: 877-889.
8. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, Kennedy M, Henckaerts E, Bonham K, Abbott GW, Linden RM, Field LJ, Keller GM. Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population. Nature. 2008; 453: 524-528.
9. Kattman SJ, Huber TL, Keller GM. Multipotent flk-1+ cardiovascular progenitor cells give rise to the cardiomyocyte, endothelial, and vascular smooth muscle lineages. Dev Cell. 2006; 11: 723-732.
10. Shi Y, Seto E, Chang LS, Shenk T. Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein. Cell. 1991; 67: 377-388.
11. Seto E, Shi Y, Shenk T. YY1 is an initiator sequence-binding protein that directs and activates transcription in vitro. Nature. 1991; 354: 241-245.
12. Gordon S, Akopyan G, Garban H, Bonavida B. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene. 2006; 25: 1125-1142.
13. Donohoe ME, Zhang X, McGinnis L, Biggers J, Li E, Shi Y. Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality. Mol Cell Biol. 1999; 19: 7237-7244.
14. Atchison L, Ghias A, Wilkinson F, Bonini N, Atchison ML. Transcription factor YY1 functions as a PcG protein in vivo. EMBO J. 2003; 22: 1347-1358.
15. Lee TC, Zhang Y, Schwartz RJ. Bifunctional transcriptional properties of YY1 in regulating muscle actin and c-myc gene expression during myogenesis. Oncogene. 1994; 9: 1047-1052.
16. Vincent CK, Gualberto A, Patel CV, Walsh K. Different regulatory sequences control creatine kinase-M gene expression in directly injected skeletal and cardiac muscle. Mol Cell Biol. 1993; 13: 1264-1272.
17. Chen CY, Schwartz RJ. Competition between negative acting YY1 versus positive acting serum response factor and tinman homologue Nkx-2.5 regulates cardiac alpha-actin promoter activity. Mol Endocrinol. 1997; 11: 812-822.
18. MacLellan WR, Lee TC, Schwartz RJ, Schneider MD. Transforming growth factor-beta response elements of the skeletal alpha-actin gene. Combinatorial action of serum response factor, YY1, and the SV40 enhancer-binding protein, TEF-1. J Biol Chem. 1994; 269: 16754-16760.
19. Mariner PD, Luckey SW, Long CS, Sucharov CC, Leinwand LA. Yin Yang 1 represses alpha-myosin heavy chain gene expression in pathologic cardiac hypertrophy. Biochem Biophys Res Commun. 2005; 326: 79-86.
20. Bhalla SS, Robitaille L, Nemer M. Cooperative activation by GATA-4 and YY1 of the cardiac B-type natriuretic peptide promoter. J Biol Chem. 2001; 276: 11439-11445.
21. Lindsley A, Snider P, Zhou H, Rogers R, Wang J, Olaopa M, Kruzynska-Frejtag A, Koushik SV, Lilly B, Burch JB, Firulli AB, Conway SJ. Identification and characterization of a novel Schwann and outflow tract endocardial cushion lineage-restricted periostin enhancer. Dev Biol. 2007; 307: 340-355.
22. Lee KH, Evans S, Ruan TY, Lassar AB. SMAD-mediated modulation of YY1 activity regulates the BMP response and cardiac-specific expression of a GATA4/5/6-dependent chick Nkx2.5 enhancer. Development. 2004; 131: 4709-4723.
23. Latinki? BV, Kotecha S, Mohun TJ. Induction of cardiomyocytes by GATA4 in Xenopus ectodermal explants. Development. 2003; 130: 3865-3876.
24. Bruneau BG. Chromatin remodeling in heart development. Curr Opin Genet Dev. 2010; 20: 505-511.
25. Nakamura T, Sano M, Songyang Z, Schneider MD. A Wnt-and betacatenin-dependent pathway for mammalian cardiac myogenesis. Proc Natl Acad Sci USA. 2003; 100: 5834-5839.
26. Hurlstone AF, Haramis AP, Wienholds E, Begthel H, Korving J, Van Eeden F, Cuppen E, Zivkovic D, Plasterk RH, Clevers H. The Wnt/betacatenin pathway regulates cardiac valve formation. Nature. 2003; 425: 633-637.
27. Kwon C, Cordes KR, Srivastava D. Wnt/beta-catenin signaling acts at multiple developmental stages to promote mammalian cardiogenesis. Cell Cycle. 2008; 7: 3815-3818.
28. Qiu GR, Gong LG, He G, Xu XY, Xin N, Sun GF, Yuan YH, Sun KL. Association of the GLI gene with ventricular septal defect after the susceptibility gene being narrowed to 3.56 cM in 12q13. Chin Med J. 2006; 119: 267-274.
29. Lien CL, McAnally J, Richardson JA, Olson EN. Cardiac-specific activity of an Nkx2-5 enhancer requires an evolutionarily conserved Smad binding site. Dev Biol. 2002; 244: 257-266.
30. Gao Z, Kim GH, Mackinnon AC, Flagg AE, Bassett B, Earley JU, Svensson EC. Ets1 is required for proper migration and differentiation of the cardiac neural crest. Development. 2010; 137: 1543-1551.
31. van Loo PF, Mahtab EA, Wisse LJ, Hou J, Grosveld F, Suske G, Philipsen S, Gittenberger-de Groot AC. Transcription factor Sp3 knockout mice display serious cardiac malformations. Mol Cell Biol. 2007; 27: 8571-8582.
32. Pal R, Khanna A. Role of smad-and wnt-dependent pathways in embryonic cardiac development. Stem Cells Dev. 2006; 15: 29-39.
33. Prall OW, Menon MK, Solloway MJ, Watanabe Y, Zaffran S, Bajolle F, Biben C, McBride JJ, Robertson BR, Chaulet H, Stennard FA, Wise N, Schaft D, Wolstein O, Furtado MB, Shiratori H, Chien KR, Hamada H, Black BL, Saga Y, Robertson EJ, Buckingham ME, Harvey RP. An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell. 2007; 128: 947-59.
34. Lien CL, Wu C, Mercer B, Webb R, Richardson JA, Olson EN. Control of early cardiac-specific transcription of Nkx2-5 by a GATA-dependent enhancer. Development. 1999; 126: 75-84.
35. He A, Kong SW, Ma Q, Pu WT. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc Natl Acad Sci USA. 2011; 108: 5632-5637.
36. Olson EN. Gene regulatory networks in the evolution and development of the heart. Science. 2006; 313: 1922-1927.
37. Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis. Cell. 2006; 126: 1037-1048.
38. Schwartz RJ, Olson EN. Building the heart piece by piece: modularity of cis-elements regulating Nkx2-5 transcription. Development. 1999; 126: 4187-4192.
39. Harvey RP. Patterning the vertebrate heart. Nat Rev Genet. 2002; 3: 544-556.
40. Tanaka M, Chen Z, Bartunkova S, Yamasaki N, Izumo S. The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development. 1999; 126: 1269-1280.
41. Saga Y, Miyagawa-Tomita S, Takagi A, Kitajima S, Miyazaki Ji, Inoue T. MesP1 is expressed in the heart precursor cells and required for the formation of a single heart tube. Development. 1999; 126: 3437-3447.
42. Saga Y, Kitajima S, Miyagawa-Tomita S. Mesp1 expression is the earliest sign of cardiovascular development. Trends Cardiovasc Med. 2000; 10: 345-352.
43. Kitajima S, Takagi A, Inoue T, Saga Y. MesP1 and MesP2 are essential for the development of cardiac mesoderm. Development. 2000; 127: 3215-3226.
44. Bondue A, Lapouge G, Paulissen C, Semeraro C, Iacovino M, Kyba M, Blanpain C. Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification. Cell Stem Cell. 2008; 3: 69-84.
45. Lindsley RC, Gill JG, Murphy TL, Langer EM, Cai M, Mashayekhi M, Wang W, Niwa N, Nerbonne JM, Kyba M, Murphy KM. Mesp1 coordinately regulates cardiovascular fate restriction and epithelial-mesenchymal transition in differentiating ESCs. Cell Stem Cell. 2008; 3: 55-68.
46. Thomas NA, Koudijs M, van Eeden FJ, Joyner AL, Yelon D. Hedgehog signaling plays a cell-autonomous role in maximizing cardiac developmental potential. Development. 2008; 135: 3789-3799.
47. Vincent SD, Buckingham ME. How to make a heart: the origin and regulation of cardiac progenitor cells. Curr Top Dev Biol. 2010; 90: 1-41.
48. Beh J, Shi W, Levine M, Davidson B, Christiaen L. FoxF is essential for FGF-induced migration of heart progenitor cells in the ascidian Ciona intestinalis. Development. 2007; 134: 3297-3305.
49. Komuro I, Izumo S. Csx: a murine homeobox-containing gene specifically expressed in the developing heart. Proc Natl Acad Sci USA. 1993; 90: 8145-8149.
50. Lyons I, Parsons LM, Hartley L, Li R, Andrews JE, Robb L, Harvey RP. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev. 1995; 9: 1654-1666.
51. Molkentin JD, Lin Q, Duncan SA, Olson EN. Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis. Genes Dev. 1997; 11: 1061-1072.
52. Seo S, Kume T. Forkhead transcription factors, Foxc1 and Foxc2, are required for the morphogenesis of the cardiac outflow tract. Dev Biol. 2006; 296: 421-436.
53. Kousteni S, Kockar FT, Sweeney GE, Ramji DP. Characterisation and developmental regulation of the Xenopus laevis CCAAT-enhancer binding protein beta gene. Mech Dev. 1998; 77: 143-148.
54. Kuo CT, Morrisey EE, Anandappa R, Sigrist K, Lu MM, Parmacek MS, Soudais C, Leiden JM. GATA4 transcription factor is required for ventral morphogenesis and heart tube formation. Genes Dev. 1997; 11: 1048-1060.
55. Mesbah K, Harrelson Z, Théveniau-Ruissy M, Papaioannou VE, Kelly RG. Tbx3 is required for outflow tract development. Circ Res. 2008; 103: 743-750.
56. Latinkic BV, Cooper B, Smith S, Kotecha S, Towers N, Sparrow D, Mohun TJ. Transcriptional regulation of the cardiac-specific MLC2 gene during Xenopus embryonic development. Development. 2004; 131: 669-679.